Surgery in Endometrial Cancer: An Audit of Quality Across Centers in India

  • S. VidhyalakshmiEmail author
  • Amita Maheshwari
  • Latha Balasubramani
Original Article



Surgical management is the cornerstone in the treatment of endometrial cancer. However, there are many controversies involved in the management starting from what constitutes adequate staging to the type of adjuvant treatment. In India, surgeons from several specialties operate on patients with endometrial cancer and there is a lack of guideline-based practice which necessitates an audit on the quality of care offered to women with endometrial cancer.


The study was a questionnaire-based study conducted at various conference venues. The study participants included general surgeons, gynecologists, surgical oncologists and gynecologic oncologists who operate on endometrial cancer.


There is an extensive variation in the management of endometrial cancer among practitioners and lack of consensus regarding lymphadenectomy and its extent during surgery. Also, the use of intraoperative frozen section and comprehensive staging is more commonly seen among oncosurgeons when compared to other specialties.


Oncologists Quality control Endometrial cancer Surgery 


Compliance with Ethical Standards

Conflict of interest

All the authors declare that there is no conflict of interest.


  1. 1.
    Jemal A, Bray F, Ferlay J. Global cancer statistics: 2011. CA Cancer J Clin. 1999;49(2):1,33–64.Google Scholar
  2. 2.
    Plaxe SC, Mundt AJ. Overview of endometrial carcinoma. In: Goff B, Dizon DS, Vora SR, Falk SJ, editors. UpToDate. The Netherlands: Wolters Kluwer Health;2015.Google Scholar
  3. 3.
    Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008;198(2):218.e1–6.CrossRefGoogle Scholar
  4. 4.
    Fay Ferkle N, Nicole McMillian P, Jillian Scavone M, Dorigo O, Eifel PJ, Fisher CM, et al. NCCN guidelines index uterine neoplasms TOC discussion NCCN guidelines version 2.2016 panel members uterine neoplasms MD/Liaison Dana-Farber/Brigham and Women’s Cancer Center.Google Scholar
  5. 5.
    Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300–8.CrossRefGoogle Scholar
  6. 6.
    Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60(8 Suppl):2035–41.CrossRefGoogle Scholar
  7. 7.
    Practice Bulletin No. 149. Obstet Gynecol. 2015 Apr;125(4):1006–26.Google Scholar
  8. 8.
    Giede C, Sk S, Le T, On O, Power P, NlS John, et al. Joint SoGC-GoC-SCC clinical practice guideline the role of surgery in endometrial cancer SoGC-GoC-SCC PoliCY and practice guidelines committee. J Obs Gynaecol Can. 2013;35(2894):1–8.Google Scholar
  9. 9.
    Díaz-Montes TP, Zahurak ML, Giuntoli RL, Gardner GJ, Bristow RE. Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecol Oncol. 2006;103(3):1043–7.CrossRefGoogle Scholar
  10. 10.
    Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014;40(2):301–11.CrossRefGoogle Scholar
  11. 11.
    de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19(3):295–309.CrossRefGoogle Scholar
  12. 12.
    Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, Mcgree ME, et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obs Gynecol. 2014;124(1):307–15.CrossRefGoogle Scholar
  13. 13.
    Writing committee on behalf of the ASTEC study group T. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.Google Scholar
  14. 14.
    Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.CrossRefGoogle Scholar
  15. 15.
    Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2. J Clin Oncol. 2009;27:5331–6.CrossRefGoogle Scholar
  16. 16.
    Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer 99mTc and/or blue dye. Ann Surg Oncol. 2016; Scholar
  17. 17.
    Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol. 2012;124(1):78–82.CrossRefGoogle Scholar
  18. 18.

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Department of OBGGKNM HospitalCoimbatoreIndia
  2. 2.Department of Gynecologic OncologyTata Memorial HospitalMumbaiIndia
  3. 3.VN Cancer CentreGKNM HospitalCoimbatoreIndia

Personalised recommendations